Combining Clinicopathological Parameters and Molecular Indicators to Predict Lymph Node Metastasis in Endometrioid Type Endometrial Adenocarcinoma

BackgroundLymph node metastasis (LNM) is a critical unfavorable prognostic factor in endometrial cancer (EC). At present, models involving molecular indicators that accurately predict LNM are still uncommon. We addressed this gap by developing nomograms to individualize the risk of LNM in EC and to...

Full description

Bibliographic Details
Main Authors: Peng Jiang, Yuzhen Huang, Yuan Tu, Ning Li, Wei Kong, Feiyao Di, Shan Jiang, Jingni Zhang, Qianlin Yi, Rui Yuan
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.682925/full
_version_ 1818690340579704832
author Peng Jiang
Yuzhen Huang
Yuan Tu
Ning Li
Wei Kong
Feiyao Di
Shan Jiang
Jingni Zhang
Qianlin Yi
Rui Yuan
author_facet Peng Jiang
Yuzhen Huang
Yuan Tu
Ning Li
Wei Kong
Feiyao Di
Shan Jiang
Jingni Zhang
Qianlin Yi
Rui Yuan
author_sort Peng Jiang
collection DOAJ
description BackgroundLymph node metastasis (LNM) is a critical unfavorable prognostic factor in endometrial cancer (EC). At present, models involving molecular indicators that accurately predict LNM are still uncommon. We addressed this gap by developing nomograms to individualize the risk of LNM in EC and to identify a low-risk group for LNM.MethodsIn all, 776 patients who underwent comprehensive surgical staging with pelvic lymphadenectomy at the First Affiliated Hospital of Chongqing Medical University were divided into a training cohort (used for building the model) and a validation cohort (used for validating the model) according to a predefined ratio of 7:3. Logistics regression analysis was used in the training cohort to screen out predictors related to LNM, after which a nomogram was developed to predict LNM in patients with EC. A calibration curve and consistency index (C-index) were used to estimate the performance of the model. A receiver operating characteristic (ROC) curve and Youden index were used to determine the optimal threshold of the risk probability of LNM predicted by the model proposed in this study. Then, the prediction performance of different models and their discrimination abilities for identifying low-risk patients were compared.ResultLNM occurred in 87 and 42 patients in the training and validation cohorts, respectively. Multivariate logistic regression analysis showed that histological grade (P=0.022), myometrial invasion (P=0.002), lymphovascular space invasion (LVSI) (P=0.001), serum CA125 (P=0.008), Ki67 (P=0.012), estrogen receptor (ER) (0.009), and P53 (P=0.003) were associated with LNM; a nomogram was then successfully established on this basis. The internal and external calibration curves showed that the model fits well, and the C-index showed that the prediction accuracy of the model proposed in this study was better than that of the other models (the C-index of the training and validation cohorts was 0.90 and 0.91, respectively). The optimal threshold of the risk probability of LNM predicted by the model was 0.18. Based on this threshold, the model showed good discrimination for identifying low-risk patients.ConclusionCombining molecular indicators based on classical clinical parameters can predict LNM of patients with EC more accurately. The nomogram proposed in this study showed good discrimination for identifying low-risk patients with LNM.
first_indexed 2024-12-17T12:24:27Z
format Article
id doaj.art-d0099f57cacf4f93b4cba85085ac66d1
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-17T12:24:27Z
publishDate 2021-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-d0099f57cacf4f93b4cba85085ac66d12022-12-21T21:48:51ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-08-011110.3389/fonc.2021.682925682925Combining Clinicopathological Parameters and Molecular Indicators to Predict Lymph Node Metastasis in Endometrioid Type Endometrial AdenocarcinomaPeng JiangYuzhen HuangYuan TuNing LiWei KongFeiyao DiShan JiangJingni ZhangQianlin YiRui YuanBackgroundLymph node metastasis (LNM) is a critical unfavorable prognostic factor in endometrial cancer (EC). At present, models involving molecular indicators that accurately predict LNM are still uncommon. We addressed this gap by developing nomograms to individualize the risk of LNM in EC and to identify a low-risk group for LNM.MethodsIn all, 776 patients who underwent comprehensive surgical staging with pelvic lymphadenectomy at the First Affiliated Hospital of Chongqing Medical University were divided into a training cohort (used for building the model) and a validation cohort (used for validating the model) according to a predefined ratio of 7:3. Logistics regression analysis was used in the training cohort to screen out predictors related to LNM, after which a nomogram was developed to predict LNM in patients with EC. A calibration curve and consistency index (C-index) were used to estimate the performance of the model. A receiver operating characteristic (ROC) curve and Youden index were used to determine the optimal threshold of the risk probability of LNM predicted by the model proposed in this study. Then, the prediction performance of different models and their discrimination abilities for identifying low-risk patients were compared.ResultLNM occurred in 87 and 42 patients in the training and validation cohorts, respectively. Multivariate logistic regression analysis showed that histological grade (P=0.022), myometrial invasion (P=0.002), lymphovascular space invasion (LVSI) (P=0.001), serum CA125 (P=0.008), Ki67 (P=0.012), estrogen receptor (ER) (0.009), and P53 (P=0.003) were associated with LNM; a nomogram was then successfully established on this basis. The internal and external calibration curves showed that the model fits well, and the C-index showed that the prediction accuracy of the model proposed in this study was better than that of the other models (the C-index of the training and validation cohorts was 0.90 and 0.91, respectively). The optimal threshold of the risk probability of LNM predicted by the model was 0.18. Based on this threshold, the model showed good discrimination for identifying low-risk patients.ConclusionCombining molecular indicators based on classical clinical parameters can predict LNM of patients with EC more accurately. The nomogram proposed in this study showed good discrimination for identifying low-risk patients with LNM.https://www.frontiersin.org/articles/10.3389/fonc.2021.682925/fullcombined predictorsendometrial cancerlymph node metastasisnomogrampredict
spellingShingle Peng Jiang
Yuzhen Huang
Yuan Tu
Ning Li
Wei Kong
Feiyao Di
Shan Jiang
Jingni Zhang
Qianlin Yi
Rui Yuan
Combining Clinicopathological Parameters and Molecular Indicators to Predict Lymph Node Metastasis in Endometrioid Type Endometrial Adenocarcinoma
Frontiers in Oncology
combined predictors
endometrial cancer
lymph node metastasis
nomogram
predict
title Combining Clinicopathological Parameters and Molecular Indicators to Predict Lymph Node Metastasis in Endometrioid Type Endometrial Adenocarcinoma
title_full Combining Clinicopathological Parameters and Molecular Indicators to Predict Lymph Node Metastasis in Endometrioid Type Endometrial Adenocarcinoma
title_fullStr Combining Clinicopathological Parameters and Molecular Indicators to Predict Lymph Node Metastasis in Endometrioid Type Endometrial Adenocarcinoma
title_full_unstemmed Combining Clinicopathological Parameters and Molecular Indicators to Predict Lymph Node Metastasis in Endometrioid Type Endometrial Adenocarcinoma
title_short Combining Clinicopathological Parameters and Molecular Indicators to Predict Lymph Node Metastasis in Endometrioid Type Endometrial Adenocarcinoma
title_sort combining clinicopathological parameters and molecular indicators to predict lymph node metastasis in endometrioid type endometrial adenocarcinoma
topic combined predictors
endometrial cancer
lymph node metastasis
nomogram
predict
url https://www.frontiersin.org/articles/10.3389/fonc.2021.682925/full
work_keys_str_mv AT pengjiang combiningclinicopathologicalparametersandmolecularindicatorstopredictlymphnodemetastasisinendometrioidtypeendometrialadenocarcinoma
AT yuzhenhuang combiningclinicopathologicalparametersandmolecularindicatorstopredictlymphnodemetastasisinendometrioidtypeendometrialadenocarcinoma
AT yuantu combiningclinicopathologicalparametersandmolecularindicatorstopredictlymphnodemetastasisinendometrioidtypeendometrialadenocarcinoma
AT ningli combiningclinicopathologicalparametersandmolecularindicatorstopredictlymphnodemetastasisinendometrioidtypeendometrialadenocarcinoma
AT weikong combiningclinicopathologicalparametersandmolecularindicatorstopredictlymphnodemetastasisinendometrioidtypeendometrialadenocarcinoma
AT feiyaodi combiningclinicopathologicalparametersandmolecularindicatorstopredictlymphnodemetastasisinendometrioidtypeendometrialadenocarcinoma
AT shanjiang combiningclinicopathologicalparametersandmolecularindicatorstopredictlymphnodemetastasisinendometrioidtypeendometrialadenocarcinoma
AT jingnizhang combiningclinicopathologicalparametersandmolecularindicatorstopredictlymphnodemetastasisinendometrioidtypeendometrialadenocarcinoma
AT qianlinyi combiningclinicopathologicalparametersandmolecularindicatorstopredictlymphnodemetastasisinendometrioidtypeendometrialadenocarcinoma
AT ruiyuan combiningclinicopathologicalparametersandmolecularindicatorstopredictlymphnodemetastasisinendometrioidtypeendometrialadenocarcinoma